Lisa Marshall
An ancient, virus-like protein best known for its essential role in placental development may, when over-expressed, fuel ALS—aka Lou Gehrig's disease—and other neurodegenerative diseases, according to new research. The discovery opens the door to a new class of potential treatments.
Could technology like smart watches and mobile apps change how patients manage Type 1 diabetes? A $1.2 million grant is helping faculty explore ways to give patients a better quality of life.
Advances in gene-editing have made it possible to banish hereditary diseases, eradicate pests and create new life forms, but should we go there? Jennifer Doudna along with two other Nobel laureates will join a panel of world leaders for a free public forum.
A new study led by Angela Bryan, a CU Boulder professor and cancer survivor, is among the first to assess how cannabis bought over the counter at dispensaries—rather than government-supplied or synthetic varieties—impacts cancer symptoms or chemotherapy side effects.
The study of 46 million births across nearly three decades is among the first to provide population-level statistical evidence of “obstetric racism,” a term coined recently to describe a concerning pattern of maltreatment of non-white pregnant women, including a disregard for their birthing wishes.
By inhibiting a protein that helps cancer cells repair themselves, scientists hope to develop new drugs that treat resistant tumors with fewer side effects.
A new “digital nose” created with Nobel Prize-winning CU technology can provide COVID-19 test results in less than one hour with excellent accuracy. It could ultimately be used for on-the-go virus testing, diagnosis of cancer and lung diseases and more.
About two-thirds of Colorado educators say they have considered leaving the field in the past year, due in part to increased challenges stemming from the ongoing youth mental health crisis. Enter the Center for Resilience and Well-Being, CU Boulder's new center focused on educating teachers, therapists and parents to support young people while first tending to their own wellbeing.
A new study sheds light on the growing phenomenon of “patient influencers,” confirming they work closely with pharmaceutical companies and routinely provide advice about drugs to followers.
Three years after the first cases of COVID-19 emerged, scientists have a far better understanding of how it spreads, how to prevent infection and minimize symptoms, and what needs to be done to prevent the next pandemic.